2024 Speakers

Speakers

Jianqing Chang
Vice President, Regulatory Policy
TIGERMED
Feng Chen
Professor of Statistics
NANJING MEDICAL UNIVERSITY
Gang Chen
Chief Scientific Officer / Former Leader, Statistical Review Group
R&G PHARMASTUDIES / US FDA
Jie Chen
Chairman and Chief Scientific Officer
ECR GLOBAL
Nathan Chen
Chief Executive Officer
HOPE MEDICINE
PJ Chen
Co-Founder & Chief Executive Officer
CALI BIOSCIENCES
Xia Chen
Senior Vice President & Chief Medical Officer
TIGERMED
Xiaoxiang Chen
Chief Executive Officer
TENACIA BIOTECHNOLOGY
Yu Chen
China Development Head
AMGEN
Yolanda Cheng
Executive Medical Director, CNS
ELI LILLY & COMPANY
Steve Chin
Chief Medical Officer
MEDILINK THERAPEUTICS
Ming Ding
Senior Vice President and General Manager, China Operations
PPD
Yueqin Ding
Regional Director
TIGERMED
Yiming Du
Senior Vice President
HAIHE PHARMA
Tracy Gong
Director, Regulatory Affairs
ROCHE CHINA
Samantha L. Hadfield
VP, Business Segment Lead – FSP Operational Delivery
PPD
Jing He
Senior Vice President, Head of China R&D
ASTRAZENECA
Jennifer Hou
Chief Medical Officer & Director of Clinical Research Center
GOBROAD HEALTHCARE GROUP
Jieli Hu
Associate Director, Project Management
NOVOTECH
Ye Hua
Chairman & Chief Executive Officer
BIONOVA PHARMACEUTICALS
David Huang
China General Manager
MERIT
Yuta Inokuchi
Representative Director & Partner
L.E.K. CONSULTING
Darren Ji
Co-Founder, Chairman, Chief Executive Officer
ELPISCIENCE
Angela Jiang
Senior Vice General Manager, Regulatory Affairs Dept
HENGRUI PHARMA
Frank Jiang
Chief Strategy Officer
HENGRUI PHARMA
Helen Jiang
Chief Medical Officer
SHANGHAI BEST-LINK BIOSCIENCE
Xurui Jin
Partner
MINDRANK
Zhaoyu Jin
Chairman & Chief Executive Officer
FUTUREGEN
Xianyi Kong
Biostatistics Director
PPD
Jin Li
Regulatory Affairs General Manager
HENLIUS BIOTEH
Jing Li
General Manager, Global Product Development Department
HENLIUS BIOTECH
Xiao Li
Assoc. CDMD
NOVARTIS
Andrew Lin
Founder & Chief Executive Officer
LINGYI BIOTEH
Kevin Lin
Chief Executive Officer
JSURE HEALTH
Andy Liu
Head of China
NOVOTECH
Cynthia Liu
Director, Data Management
SIMCERE
Guoliang Liu
Director, Regulatory Affairs
PPD
Yanfei Liu
Director, Clinical Trials Institute
FUDAN UNIVERSITY SHANGHAI CANCER CENTER
Shun Lu
Director, Oncology Department & Deputy Director, Clinical Trial Institution
SHANGHAI CHEST HOSPITAL
Yuan Lu
Head of Clinical Strategy and Operation
ABBISKO THERAPEUTICS
Zhihong Lu
Chief Medical Officer
ZHIMENG BIOPHARMA
Dong Ma
Senior Vice President, Head of Systems Division
TAIMEI TECHNOLOGY
Donglei Mao
Editor in Chief
PHARMADJ
Barry Murphy
Chief Commercial Officer
NOVOTECH
Wenseng “Wendy” Pan
Partner, Leader of Asia Life Sciences
GOODWIN
Bin Peng
Medical Advisor
ENNOVABIO / CYTOSINLAB
Jian Peng
Executive Vice President, Clinical Development & Regulatory
ZELGEN BIOPHARMA
Yu Qi
Associate Director, Pacific Business Development & Licensing
MSD CHINA
Jeannie Qiu
General Manager, Biometrics and Data Science / Vice President, Global R&D Center
FOSUN PHARMA
Albert Ren
Vice President, Strategy & Business Development, China
PFIZER
Scott Schliebner
Vice President, Drug Development Consulting
NOVOTECH
Joan Shen
Founder & Chief Executive Officer
NEUSHEN THERAPEUTICS
Michael Shi
Executive Vice President, Head of R&D and Chief Medical Officer
HUTCHMED
Stella Shi
Chief Executive Officer & Founder
RONA THERAPEUTICS
Vela Shi
Head of Quality, China Pharma Service Group
PATHEON
Dongxu Shu
Co-Founder & Chief Executive Officer
ARGO BIOPHARMA
Mia Sun
Senior Manager
PFIZER
Xing Sun
Vice President of Biostatistics & Information Science
INNOVENT BIOLOGICS
Tetsuomi Takano
Founder & Chief Executive Officer
T2T HEALTHCARE
Amy Tang
President
SINOTAU
Weikang Tao
Corporate Vice President, General Manager of Global R&D of Innovative Medicines
QILU PHARMACEUTICALS
Gary Tong
VP, Head of Clinical Development, TDC Asia
TAKEDA
Chris Wang
Head of Enterprise Solutions Team, Shanghai Region
ALIBABA CLOUD INTELLIGENCE GROUP
Gang Wang
Senior Vice President of Industry Affairs Chief Quality Officer
JUNSHI PHARMA
Hongxia Wang
Director of General Medicine
FUDAN UNIVERSITY SHANGHAI CANCER HOSPITAL
Jonathan Wang
Chief Business Officer
ZAI LAB
Julia Wang
Vice President, Clinical Development
ELI LILLY CHINA
Parvin Wang
CNS Clinical Development Head
HENGRUI MEDICINE
Xingli Wang
Executive President & Chief Executive Officer, Global R&D Center
FOSUN PHARMA
Yaning Wang
Founder & Chief Executive Officer
RUI NING KANG PHARMA
Ziwen Wang
Head of RLT Franchise, Oncology TA
NOVARTIS CHINA
Tingting Wu
Director
DELOITTE CONSULTING
Mengying Xia
Senior Director of Clinical Operations
AKESO BIO
Anbo Xiang
President of Clinical Division & Chief Medical Officer of Non-Oncology Diseases
CSPC
Fang Xiao
Strategy, Policy & Intelligence Lead
J&J INNOVATIVE MEDICINE
Shen Xiao
Chief Medical Officer
HASTEN BIOPHARMACEUTICAL
Catherine Xu
Associate Director, Operational Strategy Lead
NOVOTECH
Shierly Xu
Chief Executive Officer & Founder
TEDDY LAB
Jason Yang
Chief Executive Officer
CSTONE PHARMA
Xibin Yang
Account Director, Business Development
PPD
Jiaojiao Yu
Vice President,Head of DCT Business
TIGERMED
Weian Yuan
Vice President
SHUGUANG HOSPITAL
Bob Zhang
Chief Executive Officer
EPIGENIC THERAPEUTICS
Daisy Zhang
Vice President, Medical
SMARTNUCLIDE
Fangning Zhang
Partner
MCKINSEY & COMPANY
Jian Zhang
Director of Phase I Clinical Trial Center
FUDAN UNIVERSITY SHANGHAI CANCER CENTER
Linjie Zhang
Senior Consultant, Investment Data
PHARMCUBE
Neo Zhang
Managing Director
CBC GROUP
Wei Zhang
Senior Vice President, Head of Medicine, Greater China
BOEHRINGER INGELHEIM
Min Zhong
Chief Operating Officer
REGOR THERAPEUTICS
Caicun Zhou
Director, Oncology
EAST HOSPITAL AFFILIATED TO TONGJI UNIVERSITY
Ming Zhou
Chief Medical Officer
BOAN BIOTECH
Xianbo Zhou
Founder & Chief Executive Officer
ASTRANEURA
Chao Zhu
Head of Medical Science, Drug Development and Medical Affairs Center
LILLY CHINA
Yehua Zhu
Head of Clinical Science
ELPISCIENCE BIOPHARMA
Yonghong Zhu
Chief Medical Officer
EPIMAB BIOTHERAPEUTICS